Business
Business
Latest Headlines
Top Stories
Breaking News
Earnings
Biotech
Investors
Stock Alerts
IPOs
M&A
Canadian
UK
Wallstreet Events
Industry News
Industry News
Technology
Software
Banking
Automotive
Energy
More
Corp. Calendars
Dividends
Stock Splits
Buybacks
Conference Calls
Earnings Calendar
Earnings Calendar
Pos Pre-announcements
Profit Warnings
Positive Surprise
Negative Surprise
Latest Earnings
FDA Calendars
Drug Approvals
Clinical Trial Calendar
Ratings Changes
Upgrades
Downgrades
Cov Initiations
Cov. Reiterated
Economy
Economic News
US
Europe
Asia
Global
Economic Calendar
Economic Scorecard
Cryptocurrency
Crypto
Cryptocurrency
Blockchain
Markets
Markets
Morning Mkt Analysis
US Commentary
European Commentary
Asian Commentary
Canadian Commentary
Indian Commentary
Commodities
Bonds
Currencies
Politics
Politics
US
World
White House
Elections
General News
Forex
Forex
FX Top Stories
Currency Analysis
Currency Alerts
Economic Calendar
Economic Scorecard
Health
Health
Coronavirus
COVID-19 Calendar
Diet & Fitness
Cannabis
Kids Health
Men's Health
Women's Health
Cancer News
Drug Development
Mental Health
Slide Shows
Entertainment
Entertainment
Top Stories
Music news
Pop
Rock
Classic Rock
Rap/Hip-Hop
Country
Alternative
Oldies
All Genre
Content Licensing
Content Licensing
Newswires & Feeds
Content Syndication
Digital Signage Services
Radio News Services
Premium Services
Premium
Intelligent Investor
Biotech Investor
NEW
Login
More
Latest News Videos
Free Content
RSS Feeds
Press Releases
Search
Contact Us
Business
Corp. News
Latest Headlines
Biotech
Investors
Stock Alerts
IPOs
M&A
Top Stories
Breaking News
Earnings
Canadian
UK
Wallstreet Events
Industry News
Technology
Software
Banking
Automotive
Energy
More
Corp. Calendars
Dividends
Stock Splits
Buybacks
Conference Calls
Earnings Calendar
Earnings Calendar
Pos Pre-announcements
Profit Warnings
Positive Surprise
Negative Surprise
Latest Earnings
FDA Calendars
Drug Approvals
Clinical Trial Calendar
Ratings Changes
Upgrades
Downgrades
Cov Initiations
Cov. Reiterated
Economy
US
Europe
Asia
Global
Economic Calendar
Economic Scorecard
Crypto
Cryptocurrency
Blockchain
Markets
Market News
Morning Mkt Analysis
US Commentary
European Commentary
Asian Commentary
Canadian Commentary
Indian Commentary
Commodities
Bonds
Currencies
Politics
US
World
White House
Elections
General News
Forex
FX Top Stories
Currency Analysis
Currency Alerts
Economic Calendar
Economic Scorecard
Health
Health News
Coronavirus
COVID-19 Calendar
Diet & Fitness
Cannabis
Kids Health
Men's Health
Women's Health
Cancer News
Drug Development
Mental Health
Slide Shows
Entertainment
Entertainment News
Top Stories
Music News
Pop
Rock
Classic Rock
Rap/Hip-Hop
Country
Alternative
Oldies
All Genre
Content Licensing
Newswires & Feeds
Content Syndication
Digital Signage Services
Radio News Services
Premium
Intelligent Investor
Biotech Investor
Login
More
Latest News Videos
Free Content
RSS Feeds
Press Releases
Search
Contact Us
Astrazeneca Plc (AZN)
AstraZeneca's IMFINZI-Based Regimen Cuts Progression Risk By 30% In Liver Cancer Trial
6/1/2026 8:36:49 AM
AstraZeneca’s IMFINZI + IMJUDO Combo Shows Significant PFS Benefit In Phase III Trial For Unresectable Liver Cancer
6/1/2026 8:06:13 AM
Weekly Buzz: AZN, JNJ Get FDA Nod; LLY To Acquire Curevo; APGE Advances Zumilokibart
5/29/2026 10:39:40 AM
FDA Approves IMFINZI Combination With BCG For Non-muscle-invasive Bladder Cancer In Adults
5/29/2026 2:19:09 AM
AstraZeneca's IMFINZI Combination With BCG Wins FDA Nod For Non-muscle-invasive Bladder Cancer
5/29/2026 2:03:11 AM
AstraZeneca’s IMFINZI Gets US Approval In Combination With BCG For High-Risk Non-Muscle-Invasive Bladder Cancer
5/28/2026 10:06:49 PM
FDA Extends Review Of AstraZeneca's Camizestrant NDA In ESR1-Mutated Advanced Breast Cancer
5/27/2026 4:49:11 AM
FDA Delays Decision On AstraZeneca's Camizestrant NDA, Seeks Additional Data
5/27/2026 4:11:16 AM
AstraZeneca: FDA Extends PDUFA Date Related To NDA For Camizestrant
5/27/2026 2:23:33 AM
AstraZeneca Gets Positive CHMP Opinion For Camizestrant Combination In Breast Cancer
5/26/2026 2:57:04 AM
AstraZeneca, Daiichi Sankyo Get Positive CHMP Opinion For Enhertu In HER2-Positive Solid Tumours
5/26/2026 2:43:06 AM
AstraZeneca, Daiichi Sankyo Win US Approval For Datroway In 1st-line Treatment Of Metastatic Triple-negative Breast Cancer
5/26/2026 2:12:01 AM
AstraZeneca Says Camizestrant Combination Therapy Recommended For EU Approval In Breast Cancer
5/26/2026 2:06:56 AM
AstraZeneca, Daiichi Sankyo: Enhertu Wins EU Approval In HER2-Positive Tumors
5/26/2026 2:05:24 AM
FDA Approves AstraZeneca And Daiichi's Datroway For Treating Metastatic Breast Cancer
5/22/2026 11:53:13 AM
Weekly Buzz: GH Wins FDA Nod; NMPA Green Lights HCM; MDT To Acquire SPR ; BIIB HALTS BIIB112
5/22/2026 10:47:39 AM
AstraZeneca, Daiichi Sankyo's Datroway Gets Approval In US For Treatment Of Breast Cancer
5/22/2026 10:35:34 AM
Daiichi Sankyo & AstraZeneca Win U.S. Approval For Datroway In Metastatic Triple-Negative Breast Cancer
5/22/2026 9:45:52 AM
Mitie Wins 26 Mln Pound AstraZeneca Contract For Macclesfield Site
5/20/2026 7:37:24 AM
Mitie Secures New GBP 26 Mln Contract With AstraZeneca
5/20/2026 5:44:19 AM
1
2
3
4
Next
»